Quotient (NASDAQ:QTNT) was upgraded by stock analysts at ValuEngine from a “sell” rating to a “hold” rating in a report issued on Tuesday.
Several other analysts also recently weighed in on the company. Zacks Investment Research downgraded Quotient from a “hold” rating to a “strong sell” rating in a research note on Saturday, June 2nd. BidaskClub upgraded Quotient from a “hold” rating to a “buy” rating in a research note on Thursday, May 31st. Finally, BTIG Research restated a “buy” rating and issued a $10.00 price target on shares of Quotient in a research note on Wednesday, May 30th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $11.50.
Top 5 Stocks To Buy Right Now: Immunomedics, Inc.(IMMU)
Advisors' Opinion:- [By Todd Campbell]
After unveiling positive results for its lead drug, sacituzumab govitecan, in breast cancer at the influential American Society of Clinical Oncology (ASCO) conference, shares in Immunomedics (NASDAQ:IMMU) rallied by as much as 14.7% today before settling in for a gain of 9.3% at 3 p.m. EDT.
- [By Ethan Ryder]
Teachers Advisors LLC increased its position in shares of Immunomedics (NASDAQ:IMMU) by 14.9% in the 4th quarter, HoldingsChannel reports. The firm owned 211,706 shares of the biopharmaceutical company’s stock after purchasing an additional 27,385 shares during the period. Teachers Advisors LLC’s holdings in Immunomedics were worth $3,421,000 at the end of the most recent reporting period.
- [By Stephan Byrd]
Celldex Therapeutics (NASDAQ: CLDX) and Immunomedics (NASDAQ:IMMU) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership and earnings.
- [By Logan Wallace]
Rock Springs Capital Management LP bought a new position in Immunomedics, Inc. (NASDAQ:IMMU) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 450,000 shares of the biopharmaceutical company’s stock, valued at approximately $6,575,000. Rock Springs Capital Management LP owned 0.27% of Immunomedics at the end of the most recent reporting period.
- [By Logan Wallace]
Immunomedics, Inc. (NASDAQ:IMMU) Director Venbio Select Advisor Llc bought 575,000 shares of the company’s stock in a transaction on Friday, June 15th. The stock was bought at an average cost of $24.00 per share, for a total transaction of $13,800,000.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Top 5 Stocks To Buy Right Now: Argan, Inc.(AGX)
Advisors' Opinion:- [By Max Byerly]
Federated Investors Inc. PA raised its position in Argan, Inc. (NYSE:AGX) by 26.6% during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 99,678 shares of the construction company’s stock after buying an additional 20,936 shares during the period. Federated Investors Inc. PA’s holdings in Argan were worth $4,282,000 as of its most recent filing with the SEC.
- [By Joseph Griffin]
State Board of Administration of Florida Retirement System decreased its holdings in Argan, Inc. (NYSE:AGX) by 26.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,343 shares of the construction company’s stock after selling 1,907 shares during the quarter. State Board of Administration of Florida Retirement System’s holdings in Argan were worth $229,000 at the end of the most recent reporting period.
Top 5 Stocks To Buy Right Now: NorthStar Realty Europe Corp.(NRE)
Advisors' Opinion:- [By Shane Hupp]
Teachers Insurance & Annuity Association of America increased its holdings in NorthStar Realty Europe (NYSE:NRE) by 15.7% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 71,499 shares of the financial services provider’s stock after purchasing an additional 9,699 shares during the period. Teachers Insurance & Annuity Association of America owned approximately 0.13% of NorthStar Realty Europe worth $931,000 as of its most recent SEC filing.
- [By Stephan Byrd]
NorthStar Realty Europe (NYSE:NRE) has been assigned a consensus recommendation of “Buy” from the six brokerages that are presently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $17.17.
- [By Joseph Griffin]
Northstar Realty Europe Corp (NYSE:NRE) has earned an average rating of “Hold” from the six ratings firms that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and three have issued a buy recommendation on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $16.83.
Top 5 Stocks To Buy Right Now: Facebook, Inc.(FB)
Advisors' Opinion:- [By Javier Hasse]
Overall, Traackr found that while Twitter Inc (NYSE: TWTR) garners about half the mentions of cannabis brands by influencers on social media, Facebook, Inc. (NASDAQ: FB)’s Instagram down the platform that drives the most engagement for brands. The only exception is represented by the vaporizers category, which have generated significant conversation on Alphabet Inc (NASDAQ: GOOGL)’s YouTube.
- [By Wayne Duggan]
On this day six years ago, Facebook, Inc. (NASDAQ: FB) held its highly anticipated IPO.
Where The Market WasThe Dow finished the day at 12,369.38. The S&P 500 traded at 1,295.22. Today, the Dow is trading at 24,713.98 and the S&P 500 is trading at 2,720.13.
- [By Michael A. Robinson]
Make no mistake. Each member of the FANG Plus group is a great company. We're talking Facebook Inc. (Nasdaq: FB), Amazon.com Inc. (Nasdaq: AMZN), Netflix Inc. (Nasdaq: NFLX), and Alphabet Inc. (Nasdaq: GOOGL) – plus Apple Inc. (Nasdaq: AAPL).
- [By Evan Niu, CFA]
The Cambridge Analytica privacy scandal continues to engulf Facebook (NASDAQ:FB), with CEO Mark Zuckerberg set to testify to Congress this week in what promises to be an epic grilling. Zuckerberg's defense�that "Facebook is an idealistic and optimistic company" and never gave serious consideration to how its platform could be hijacked for malicious purposes is rather naive.
- [By Alison Southwick and Robert Brokamp, CFP]
In this episode of Motley Fool Answers, Robert Brokamp and Alison Southwick are joined by Matt Argersinger of Million Dollar Portfolio and Supernova to talk about the powerful and popular FAANG stocks, which over the longer term -- and particularly, the last five years -- have delivered stellar returns to shareholders. But the past few months have brought trouble and upheaval to the tech sector, and public response to privacy problems could put a crimp in the progress of companies like Facebook�(NASDAQ:FB) and Alphabet�(NASDAQ:GOOGL) (NASDAQ:GOOG).
- [By Michael A. Robinson]
Based on the early days of what eventually became Facebook Inc. (Nasdaq: FB), the movie portrayed Zuckerberg as not only brilliant – but also as an egomaniac with a talent for making enemies.
Top 5 Stocks To Buy Right Now: Vascular Biogenics Ltd.(VBLT)
Advisors' Opinion:- [By Lisa Levin]
Check out these big penny stock gainers and losers
Losers ReTo Eco-Solutions, Inc. (NASDAQ: RETO) fell 9.3 percent to $4.50 in pre-market trading. ProPhase Labs, Inc. (NASDAQ: PRPH) shares fell 8.5 percent to $4.50 in pre-market trading after dropping 3.53 percent on Thursday. Nordstrom, Inc. (NYSE: JWN) fell 7.5 percent to $47.10 in pre-market trading. Nordstrom reported upbeat results for its first quarter. Comparable-store sales rose 0.6 percent. Baidu, Inc. (NASDAQ: BIDU) shares fell 6 percent to $263.00 in pre-market trading. Baidu disclosed that its COO Qi Lu will step down in July 2018. Riot Blockchain, Inc. (NASDAQ: RIOT) shares fell 5.6 percent to $8.98 in pre-market trading after climbing 11.88 percent on Thursday. Applied Materials, Inc. (NASDAQ: AMAT) fell 5 percent to $51.30 in pre-market trading. Applied Materials reported stronger-than-expected results for its second quarter, but issued weak sales outlook for the third quarter. Blink Charging Co. (NASDAQ: BLNK) fell 5 percent to $7.61 in pre-market trading after rising 11.40 percent on Thursday. Illumina, Inc. (NASDAQ: ILMN) shares fell 4.7 percent to $255.77 in pre-market trading. Vascular Biogenics Ltd (NASDAQ: VBLT) fell 4.6 percent to $2.10 in pre-market trading after reporting a first-quarter earnings miss. Campbell Soup Company (NYSE: CPB) fell 3.3 percent to $37.60 in pre-market trading. Campbell Soup reported upbeat Q3 earnings, but sales missed estimates. The company also lowered its FY18 outlook. ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares fell 2.7 percent to $17.65 in pre-market trading after reporting a 7.2 million common stock offering - [By Lisa Levin] Companies Reporting Before The Bell Walmart Inc. (NYSE: WMT) is estimated to report quarterly earnings at $1.13 per share on revenue of $120.51 billion. J. C. Penney Company, Inc. (NYSE: JCP) is expected to report quarterly loss at $0.2 per share on revenue of $2.63 billion. Dillard's, Inc. (NYSE: DDS) is projected to report quarterly earnings at $2.77 per share on revenue of $1.46 billion. The Children's Place, Inc. (NASDAQ: PLCE) is estimated to report quarterly earnings at $2.21 per share on revenue of $444.14 million. Manchester United plc (NYSE: MANU) is expected to report quarterly loss at $1.35 per share on revenue of $193.67 million. Teekay Corporation (NYSE: TK) is estimated to report quarterly loss at $0.08 per share on revenue of $296.76 million. KEMET Corporation (NYSE: KEM) is projected to report quarterly earnings at $0.41 per share on revenue of $306.72 million. Vascular Biogenics Ltd. (NASDAQ: VBLT) is estimated to report a quarterly loss at $0.21 per share. Teekay Offshore Partners L.P. (NYSE: TOO) is expected to report quarterly earnings at $0.04 per share on revenue of $272.04 million. Albireo Pharma, Inc. (NASDAQ: ALBO) is expected to report quarterly earnings at $1.77 per share on revenue of $31.32 million.
No comments:
Post a Comment